Difficulty: Medium
Average Score: 80%
Practice
A 50-year-old male with type 2 diabetes is prescribed empagliflozin. Empagliflozin works by:
Correct answer
A
Rationale
Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes. The correct answer is A) Inhibiting the reabsorption of glucose in the kidneys. SGLT2 inhibitors like empagliflozin work by blocking the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion and lower blood glucose levels.
Option B) Improving insulin sensitivity in peripheral tissues is incorrect because SGLT2 inhibitors do not directly affect insulin sensitivity. Option C) Increasing insulin secretion from the pancreas is incorrect as SGLT2 inhibitors do not act on pancreatic insulin secretion. Option D) Inhibiting the enzyme that breaks down incretin hormones is incorrect because SGLT2 inhibitors do not target incretin hormones.
In an educational context, understanding how empagliflozin works is crucial for healthcare professionals managing patients with type 2 diabetes. By knowing that empagliflozin inhibits glucose reabsorption in the kidneys, healthcare providers can make informed decisions about treatment strategies and educate patients on the mechanism of action of their medications. This knowledge helps optimize patient care and outcomes in the management of diabetes.
Option B) Improving insulin sensitivity in peripheral tissues is incorrect because SGLT2 inhibitors do not directly affect insulin sensitivity. Option C) Increasing insulin secretion from the pancreas is incorrect as SGLT2 inhibitors do not act on pancreatic insulin secretion. Option D) Inhibiting the enzyme that breaks down incretin hormones is incorrect because SGLT2 inhibitors do not target incretin hormones.
In an educational context, understanding how empagliflozin works is crucial for healthcare professionals managing patients with type 2 diabetes. By knowing that empagliflozin inhibits glucose reabsorption in the kidneys, healthcare providers can make informed decisions about treatment strategies and educate patients on the mechanism of action of their medications. This knowledge helps optimize patient care and outcomes in the management of diabetes.